Search Results

Filter
  • 1-10 of  174 results for ""Angiotensin II Type 1 Receptor Blockers""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Losartan protects endothelium-dependent relaxation in vivo in a murine model of rheumatoid arthritis.

  • Authors : Villaluz M; Centre of Musculoskeletal Science, Institute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley, United Kingdom.; Dunning L

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Arthritis, Experimental/Arthritis, Experimental/Arthritis, Experimental/*drug therapy ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: European journal of pharmacology [Eur J Pharmacol] 2021 Aug 05; Vol. 904, pp. 174133. Date of Electronic Publication: 2021 May 10.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: A meta-analysis.

  • Authors : Kang H; School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.; Zhang J

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use

  • Source: European journal of pharmacology [Eur J Pharmacol] 2020 Oct 05; Vol. 884, pp. 173444. Date of Electronic Publication: 2020 Jul 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways.

  • Authors : Abo El-Nasr NME; Department of Pharmacology, Medical Division, National Research Centre, Giza, Egypt. Electronic address: .; Saleh DO

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Diabetes Complications/Diabetes Complications/Diabetes Complications/*drug therapy ; Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*drug therapy

  • Source: European journal of pharmacology [Eur J Pharmacol] 2020 May 05; Vol. 874, pp. 173010. Date of Electronic Publication: 2020 Feb 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile Paget disease.

  • Authors : Tsuruda T; Department of Internal Medicine, Circulatory and Body Fluid Regulation, University of Miyazaki, 889-1692, Japan. Electronic address: .; Funamoto T

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Bone Density/Bone Density/Bone Density/*drug effects ; Myocardial Contraction/Myocardial Contraction/Myocardial Contraction/*drug effects Hyperostosis corticalis deformans juvenilis

  • Source: European journal of pharmacology [Eur J Pharmacol] 2019 Sep 15; Vol. 859, pp. 172519. Date of Electronic Publication: 2019 Jul 02.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma.

  • Authors : Kim MJ; College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.; Im DS

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/*pharmacology ; Asthma/Asthma/Asthma/*drug therapy

  • Source: European journal of pharmacology [Eur J Pharmacol] 2019 Jun 05; Vol. 852, pp. 25-33. Date of Electronic Publication: 2019 Feb 21.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock.

  • Authors : Fernandes D; Department of Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, Brazil.; Pacheco LK

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Arterial Pressure/Arterial Pressure/Arterial Pressure/*drug effects ; Hypotension/Hypotension/Hypotension/*drug therapy

  • Source: European journal of pharmacology [Eur J Pharmacol] 2021 Apr 15; Vol. 897, pp. 173953. Date of Electronic Publication: 2021 Feb 20.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.

  • Authors : Parit R; Department of Biotechnology (DDE), Madurai Kamaraj University, Madurai, 625021, Tamilnadu, India.; Jayavel S

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/metabolism ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: European journal of pharmacology [Eur J Pharmacol] 2021 Apr 05; Vol. 896, pp. 173899. Date of Electronic Publication: 2021 Jan 27.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells.

  • Authors : Kataoka H; Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.; Murakami R

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Endothelial Cells/Endothelial Cells/Endothelial Cells/*drug effects ; Endothelial Cells/Endothelial Cells/Endothelial Cells/*metabolism

  • Source: European journal of pharmacology [Eur J Pharmacol] 2010 Jun 25; Vol. 636 (1-3), pp. 36-41. Date of Electronic Publication:Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.

  • Authors : Xu C; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China.; Fang D

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacology ; Benzoates/Benzoates/Benzoates/*pharmacology

  • Source: European journal of pharmacology [Eur J Pharmacol] 2015 Sep 05; Vol. 762, pp. 364-71. Date of Electronic Publication: 2015 Jun 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.

  • Authors : Ibrahim MA; Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia, Egypt. Electronic address: .; Amin EF

Subjects: Acetates/Acetates/Acetates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use

  • Source: European journal of pharmacology [Eur J Pharmacol] 2014 Feb 05; Vol. 724, pp. 204-10. Date of Electronic Publication: 2013 Dec 24.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  174 results for ""Angiotensin II Type 1 Receptor Blockers""